TABLE 2-1 Vaccines in Widespread Use, 1985–2020
	1985 2000 2020a Adult influenza   Adult influenza   Adult influenzac Adult pneumococcal polysaccharide   Adult pneumococcal polysaccharide   Adult pneumococcal polysaccharide Diphtheria, pertussis, tetanus, and components   Diphtheria, tetanus, acellular pertussis, and components b   DTaPc Measles, mumps, and rubella   MMRb   Measles, mumps, rubella, and varicellac Oral poliovirus   Inactivated poliovirusb   Eradication of polio expected     H. influenzae type bb   Hibc     Hepatitis Ab   Hepatitis Ac     Hepatitis Bb   Hepatitis Bc     Varicellab   Varicella with MMR     Pediatric conjugate of pneumococcal polysaccharide   Pediatric conjugate of pneumococcal polysaccharidec     Borrelia burgdorferi   Borrelia burgdorferi     Meningococcal polysaccharide A,C,Y,W-135   Conjugated meningococcal polysaccharide A,B,C,Y,W-135c         Adult tetanus, diphtheria, acellular pertussis, and componentsc         Chlamydia         Coccidioides immites         Cytomegalovirus         Enterotoxigenic E.coli         Epstein-Barr         Helicobacter pyloric         Hepatitis Cc         Herpes simplex         Histoplasma capsulatum         Human papillomavirusc         Child influenzac         Insulin-dependent diabetes mellitus (therapeutic)         Melanoma (therapeutic)         Multiple sclerosis (therapeutic)         Mycobacterium tuberculosis         Neisseria gonorrhea         Neisseria meningitidis B         Parainfluenzac         Respiratory syncytial virusc         Rheumatoid arthritis (therapeutic)         Rotavirusc         Shigella         Streptococcus, Group Ac         Streptococcus, Group B
a Priority candidate vaccines, drawn from IOM, 1999b. b Vaccines covered by Vaccines for Children (VFC) as of February 2000. c Vaccines likely to be recommended for universal use (including VFC coverage for childhood vaccines).